Maintaining OAB Patient Success
The literature is quite expressive when it comes to frequency of PTNS treatments after the initial 12 are completed. Generally, once a month will be the standard for retreatment. However, you will find that with some patients, treatments are needed more frequently or less frequently.
Individualizing treatments is the most important strategy you can use with your patients. It saves time, money and clinic space. For most practices that works, for some it doesn’t. We work really hard to keep the effects of bladder irritants and practicing urge reduction techniques along with many other things in the forefront of our patients daily activities.
In the older adult, we also enlist the help of the spouse, friend, family or caregiver to reinforce these teachings. These “allies” generally know when it's time to come in. They realize the rules and help patients stay in compliance.
All that being said, after the 12th treatment we will always schedule the next patient in 4 weeks. When we review their history and current state of urgency, we may stretch the next appointment to 5 weeks, then 6 weeks, then 2 months. If it’s too long, we cut back to the “breaking point” and continue to schedule at that interval.
On the other hand, if symptoms have returned sooner than the 4 weeks, the patient is instructed to call for an appointment. The other option you have is leaving re-treatment up to the patient and encouraging them to come in when they feel their urgency and/or urge incontinence is returning. This is a little risky especially if your clinic has minimal clinic space or staff to accommodate a same day or next day appointment. Whatever policy your office chooses to adopt, keep your patient outcomes in mind. A dry patient is a happy patient!
This blog post reflects the opinions and experience of Leslie Wooldridge, a long-standing user of the Urgent PC Neuromodulation System, and was produced under a paid consulting agreement with Cogentix Medical.
Urgent PC is indicated for the treatment of Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Treatment with Urgent PC is contraindicated for patients with pacemakers or implantable defibrillators, patients prone to excessive bleeding, patients with nerve damage that could impact either percutaneous tibial nerve or pelvic floor function or patients who are pregnant or planning to become pregnant during the duration of the treatment. Most patients don't experience side-effects. If side-effects occur, they are typically temporary and include mild pain and skin inflammation at or near the stimulation site. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For complete instructions for use, storage, warnings, indications, contraindications, precautions, adverse reactions and disclaimer of warranties, please refer to the insert accompanying each product or online at www.cogentixmedical.com. Models are for illustrative purposes only. Urgent is a registered trademark of Cogentix Medical © 2015 Cogentix Medical. All rights reserved.